Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

darolutamide

(DAR-oh-LOO-tuh-mide)
A drug used alone or with docetaxel to treat adults with certain types of prostate cancer. Darolutamide is used in patients whose cancer has spread to other parts of the body and responds to treatment that lowers testosterone levels or whose cancer has not spread to other parts of the body and no longer responds to treatment that lowers testosterone levels. It is also being studied in the treatment of other types of cancer. Darolutamide binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Darolutamide blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called Nubeqa.
More Information
Search NCI's Dictionary of Cancer Terms